Default: Medwave

ISSN:

Journal Home

Journal Guideline

Medwave Q3 Unclaimed

Chile
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Medwave is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 19. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 540 €. The scope of the journal is focused on clinical medicine, public health, ethics, methodology, evidence-based summaries, biomedical research. It has an SJR impact factor of 0,322 and it has a best quartile of Q3. It is published in English, Spanish; Castilian. It has an SJR impact factor of 0,322.

Medwave focuses its scope in these topics and keywords: case, report, therapy, chemotherapy, chest, combined, dietary, disease, due, education, ...

Type: Journal

Type of Copyright: CC BY-NC

Languages: English, Spanish; Castilian

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Issues, Ethics and Legal Aspects (Q3) Medicine (miscellaneous) (Q3) Public Health, Environmental and Occupational Health (Q3)
Price

540 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Medwave

0,322

SJR Impact factor

19

H Index

66

Total Docs (Last Year)

190

Total Docs (3 years)

1873

Total Refs

199

Total Cites (3 years)

182

Citable Docs (3 years)

0.71

Cites/Doc (2 years)

28.38

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


case, report, therapy, chemotherapy, chest, combined, dietary, disease, due, education, effect, factors, hand, hospitalized, hypothyroidismpalliative, importance, incognito, lesionsantioxidant, levothyroxine, line, liothyronine, literature, medical, mentagrophytes, metastatic, mouth, mucocutaneous, multiple, national, necrotizing, patients, peruvian, physiotherapy, pneumoniaa, reportwhat, research, reviewtinea, clinical medicine, public health, ethics, methodology, evidence-based summaries, biomedical research

FAQS